LifeMD, Inc.LFMDNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -100.00% |
| Q3 2025 | 3.72% |
| Q2 2025 | 2.58% |
| Q1 2025 | 10.97% |
| Q4 2024 | -7.70% |
| Q3 2024 | 8.71% |
| Q2 2024 | 15.11% |
| Q1 2024 | 4.47% |
| Q4 2023 | 33.36% |
| Q3 2023 | 8.51% |
| Q2 2023 | 16.65% |
| Q1 2023 | 16.13% |
| Q4 2022 | 24.04% |
| Q3 2022 | 17.20% |
| Q2 2022 | 63.67% |
| Q1 2022 | 24.73% |
| Q4 2021 | 168.01% |
| Q3 2021 | 4.51% |
| Q2 2021 | -36.22% |
| Q1 2021 | 21.71% |
| Q4 2020 | 33.45% |
| Q3 2020 | 28.18% |
| Q2 2020 | 18.15% |
| Q1 2020 | 19.96% |
| Q4 2019 | 6.40% |
| Q3 2019 | 20.42% |
| Q2 2019 | 11.15% |
| Q1 2019 | -62.06% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |